evidence: Consistent with prior reports on ABP measurements in sorafenib-treated patients(4), this independent cohort of normotensive patients had significant elevations of systolic blood pressure (SBP)
intervention: Sorafenib
comparator: Control
outcome: Systolic blood pressure 